Q2 2010

Filed Aug 5, 2010 · 10-Q · 36 days after period end · 0000950123-10-073360

Q2 2010 · 10-Q

Revenue—

Net Income

$154.00K

no prior Q2 2009 on file

EPS Diluted

-$0.02

no prior Q2 2009 on file

Operating Income-$2,853,000—

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 5, 2010 · 36 d after period end

Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR